BRISTOL-MYERS SQUIBB COMPANY

Official Publications Bristol-Myers Squibb Company Borsa Italiana

Equities

4BMY

US1101221083

Real-time Estimate Tradegate Other stock markets 07:56:53 03/07/2024 pm IST			5-day change	1st Jan Change
37.3 ^EUR	-1.61%		-3.99%	-18.29%

02/07	Cartesian Therapeutics, Inc. Appoints Kemal Malik to its Board of Directors	CI
01/07	Bristol-Myers Squibb to Pay $2.7 Million to Settle Potential Anti-Competition Case, Israeli Agency Says	MT

Official Publications

SEC Filing 10Q-1	27/23/27	CO
Slide show Q1	27/23/27	CO
1st quarter results	27/23/27	CO
Annual Report	27/23/27	CO
SEC Filing 8K	27/23/27	CO
SEC Filing 8K	26/23/26	CO
Proxy Statments	23/23/23	CO
SEC Filing 10K	14/23/14	CO
Slide show results	02/23/02	CO
Annual results	02/23/02	CO
SEC Filing 8K	02/23/02	CO
SEC Filing 8K	31/23/31	CO
SEC Filing 8K	09/23/09	CO
Slide show Q3	26/22/26	CO
3rd quarter results	26/22/26	CO
SEC Filing 10Q-2	26/22/26	CO
SEC Filing 8K	26/22/26	CO
SEC Filing 8K	27/22/27	CO
SEC Filing 10Q-2	27/22/27	CO
1st-half-year results	27/22/27	CO
Slide show half-year results	27/22/27	CO
SEC Filing 4K	16/22/16	CO
SEC Filing 8K	15/22/15	CO
Dividends	15/22/15	CO
Slide show Q1	29/22/29	CO

1 2 3

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Headlines

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

January 09, 2024 at 11:36 pm IST

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer